Patent and Consent Policy - International Multispeciality Journal of Health (IJOER)

IJOER Patent and Consent Policy: Intellectual Property Protection and Research Consent Guidelines

Legal Compliance Required
Important Legal Notice

Authors are responsible for:

  • Obtaining requisite permissions to quote from other works
  • Obtaining permissions from individuals before mentioning them by name, voice, photograph, or likeness
  • Ensuring that publication does not violate any patent rights
  • Understanding that early publication may prejudice patent rights in some countries
Our Commitment to Intellectual Property Protection

International Multispeciality Journal of Health recognizes the protection of intellectual property rights while encouraging dissemination of scholarly research. Our policy on patent and consent addresses the complex intersection of academic publishing, patent protection, and ethical research conduct.

This policy guides authors through considerations about patents, obtains proper consent for research involving human subjects, and describes how intellectual property issues may be handled in the publication process.

IJOER Patent and Consent Policy - Intellectual Property Protection and Research Ethics Guidelines

Patent Considerations and Disclosure

Required Disclosures
  • Pending patent applications
  • Patents granted related to the research
  • Planned patent filings
  • Institutional patent policies
  • Commercialization agreements
  • Material Transfer Agreements
  • Confidentiality constraints
Timing of Disclosure
  1. During manuscript submission
  2. Prior to peer review initiation
  3. Before manuscript acceptance
  4. Upon discovery of new patent issues
  5. During revision process, if applicable
  6. Before final publication

Publication and Patentability

Possible Impacts
  • Prior art creation that influences novelty
  • Public disclosure triggering deadlines
  • Variations in grace periods among jurisdictions
  • Impact on international patent filings
  • Commercial value implications
  • Licensing opportunity considerations
Recommended Actions
  • Consult with patent attorneys before submitting
  • File patent applications prior to publication
  • Understand jurisdiction-specific grace periods
  • Coordinate with institutional technology transfer offices
  • Consider provisional patent applications
  • Plan international filing strategies

International Patent Grace Periods

Grace Periods by Jurisdiction
Jurisdiction Grace Period Conditions
United States 12 months From first public disclosure by inventor
Japan 12 months From first public disclosure
South Korea 12 months From first public disclosure
Canada 12 months From first public disclosure
Australia 12 months From first public disclosure
European Patent Office 6 months Limited circumstances only
China 6 months Limited to some international exhibitions
India 12 months From first public disclosure
Important Legal Notice

Grace periods are complex and subject to change. Authors should consult with patent professionals in relevant jurisdictions before publication.

Patent Strategy Recommendations

File First, Publish Later

Submit patent applications before manuscript submission to secure priority dates.

Provisional Applications

Use provisional patents to establish early filing dates while continuing research.

International Filing

Plan PCT applications for comprehensive international patent protection.

Institutional Support

Collaborate with university technology transfer offices for guidance and support.

Informed Consent in Research

Consent Elements
  • Purpose of the research
  • Procedures and duration
  • Potential risks and benefits
  • Confidentiality protections
  • Voluntary participation
  • Right to withdraw
  • Contact details
  • Publication intentions
Documentation Requirements
  • Written consent forms
  • Institutional Review Board approval
  • Ethics committee certification
  • Data protection compliance
  • Participant information sheets
  • Consent verification processes

Special Consent Considerations

Vulnerable Populations
  • Children and minors: Parental consent required
  • People with cognitive impairments: Special safeguards needed
  • Detained people and prisoners: Additional ethical considerations
  • Economically disadvantaged groups: Protection from coercion
  • Students: Ensure no undue influence
  • Employees: Protect from employer pressure
Special Contexts
  • Medical and health research: Clinical trial regulations apply
  • Indigenous communities: Community consent required
  • Cross-cultural studies: Cultural sensitivity needed
  • Sensitive topic research: Additional ethical review
  • Online and digital research: Digital consent protocols
  • Secondary data analysis: Original consent verification

Ethical Approval and Compliance

Required Approvals
  • Institutional Review Board (IRB) approval
  • Research Ethics Committee clearance
  • Institutional animal care committee approval
  • Data protection authority approval
  • Indigenous community approval
  • Government research permits
Compliance Documentation
  • Approval certificate numbers
  • Date of ethical approval
  • Name of approving institution
  • Approval validity period
  • Any special conditions
  • Renewal documentation if applicable
Ethical Compliance Statement Requirement

Manuscripts reporting research involving human subjects, animal subjects, or sensitive data should include a statement identifying the institutional review board or ethics committee that approved the study, along with the reference number where appropriate.

Patent and Consent Support

For further inquiries on questions of patent considerations, consent requirements, ethical approvals, or intellectual property issues, kindly contact our Editorial Office:

Subject Line Requirement

Please put "Patent and Consent Query" in the subject line of your email and describe your situation in as much detail as possible.

For complex patent and/or consent situations, we encourage early consultation to avoid publication delays.

Legal Guidance

Contact us early for guidance on patent and consent matters to avoid publication delays.

Contact Us